Patents by Inventor Scott J. Dylla

Scott J. Dylla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PTK7 ANTIBODY-DRUG CONJUGATES
    Publication number: 20150315293
    Abstract: The present invention provides anti-PTK7 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: April 27, 2015
    Publication date: November 5, 2015
    Applicants: STEMCENTRX, INC., PFIZER INC.
    Inventors: Marc Isaac DAMELIN, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9173959
    Abstract: Pharmaceutical compositions to treat proliferative disorders are provided.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: November 3, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9155803
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat tumors having neuroendocrine features are provided.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: October 13, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
    Publication number: 20150265724
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat tumors having neuroendocrine features are provided.
    Type: Application
    Filed: June 8, 2015
    Publication date: September 24, 2015
    Applicant: STEMCENTRX, INC.
    Inventors: Robert A. Stull, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9133271
    Abstract: Provide are novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat recurrent tumors and to reduce or inhibit tumor recurrence in a subject.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: September 15, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates for treating cancer
    Patent number: 9107961
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: August 18, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies
    Patent number: 9090683
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibodies
    Patent number: 9089615
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9089616
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9089617
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 28, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES
    Publication number: 20150125472
    Abstract: The present invention provides for anti-EFNA4 antibody-drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: October 28, 2014
    Publication date: May 7, 2015
    Applicants: STEM CENTRX, INC., PFIZER, INC.
    Inventors: Marc Isaac DAMELIN, Kiran Manohar KHANDKE, Puja SAPRA, Alexander John BANKOVICH, Scott J. DYLLA
  • Anti-DLL3 antibody drug conjugates and methods of use
    Patent number: 9011854
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: April 21, 2015
    Assignee: Stemcentrx, Inc.
    Inventors: Robert A Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Nucleic acid encoding DLL3 antibodies
    Patent number: 8986972
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: March 24, 2015
    Assignee: Stem CentRx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • IDENTIFICATION AND ENRICHMENT OF CELL SUBPOPULATIONS
    Publication number: 20150030636
    Abstract: Markers useful for the identification, characterization and, optionally, the enrichment or isolation of tumorigenic cells or cell subpopulations are disclosed.
    Type: Application
    Filed: August 7, 2014
    Publication date: January 29, 2015
    Applicant: STEM CENTRX, INC.
    Inventors: SCOTT J. DYLLA, MARIANNE SANTAGUIDA, WADE C. ANDERSON, BOB Y. LIU, SAMUEL A. WILLIAMS
  • ANTI SEZ6 ANTIBODIES AND METHODS OF USE
    Publication number: 20150018531
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: February 22, 2013
    Publication date: January 15, 2015
    Applicant: STEM CENTRX, INC.
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20140370037
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 18, 2014
    Applicant: STEM CENTRX, INC.
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20140364593
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Applicant: STEM CENTRX, INC.
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20140363826
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Applicant: STEM CENTRX, INC.
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20140363887
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Applicant: STEM CENTRX, INC.
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20140363455
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Applicant: STEM CENTRX, INC.
    Inventors: ROBERT A STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO